• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不良健康状况对老年心房颤动患者临床结局的影响:一项前瞻性队列研究的启示。

Impact of Adverse Health Conditions on Clinical Outcomes of Older People with Atrial Fibrillation: Insights from a Prospective Cohort Study.

机构信息

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

出版信息

Clin Interv Aging. 2024 Sep 6;19:1519-1528. doi: 10.2147/CIA.S464044. eCollection 2024.

DOI:10.2147/CIA.S464044
PMID:39257680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11385685/
Abstract

OBJECTIVE

To evaluate the impact of adverse health conditions, including multimorbidity, frailty, malnutrition, cognitive impairment, and polypharmacy, on clinical outcomes in older people with atrial fibrillation (AF).

PATIENTS AND METHODS

This prospective cohort study focused on patients aged 65 years and older with AF. They were admitted to the hospital between September 2018 and April 2019 and followed up for 1 year. We evaluated these participants for adverse health conditions including multimorbidity, frailty, malnutrition, cognitive impairment, and polypharmacy. The primary clinical outcome measured was a combination of all-cause mortality or rehospitalization.

RESULTS

197 older patients (≥65 years) with AF (mean age, 77.5±7.1 years; 57.4% men) were enrolled. During 1-year follow-up, Primary endpoint events (all-cause mortality or rehospitalization) occurred in 82 patients (41.6%). Compared with the non-event group, the Charlson comorbidity index (CCI) was higher (2.5±1.9 vs 1.7±1.3, p=0.004), more heart failure (32.9% vs 17.4%, p=0.01) and chronic kidney disease (17.1% vs 7.0%, p=0.03), with lower systolic blood pressure (125.3±18.3 mmHg vs 132±17.9 mmHg, p=0.005) in the event group. On multivariate Cox regression showed that the CCI was associated with a higher odds ratio of the composite outcome of all-cause mortality and rehospitalization (HR: 1.26; 95% CI: 1.02-1.56, p=0.03). Other adverse health conditions showed no significant association with the composite outcome of all-cause mortality and rehospitalization.

CONCLUSION

Among adverse health conditions in older people with AF, multimorbidity appears to be a significant determinant of adverse clinical outcomes.

CLINICAL TRIAL REGISTRATION

ChiCTR1800017204; date of registration: 07/18/2018.

摘要

目的

评估多种不良健康状况(包括多种合并症、衰弱、营养不良、认知障碍和多种药物治疗)对老年心房颤动(AF)患者的临床结局的影响。

患者和方法

本前瞻性队列研究聚焦于年龄在 65 岁及以上的 AF 患者。他们于 2018 年 9 月至 2019 年 4 月期间住院,并随访 1 年。我们评估了这些参与者的多种不良健康状况,包括多种合并症、衰弱、营养不良、认知障碍和多种药物治疗。主要临床终点测量指标是全因死亡率或再住院的综合结果。

结果

共纳入 197 名(≥65 岁)老年 AF 患者(平均年龄 77.5±7.1 岁;57.4%为男性)。在 1 年随访期间,有 82 名患者(41.6%)发生主要终点事件(全因死亡率或再住院)。与非事件组相比,Charlson 合并症指数(CCI)更高(2.5±1.9 比 1.7±1.3,p=0.004),心力衰竭(32.9%比 17.4%,p=0.01)和慢性肾脏病(17.1%比 7.0%,p=0.03)更多,而收缩压更低(125.3±18.3mmHg 比 132±17.9mmHg,p=0.005)。多变量 Cox 回归显示,CCI 与全因死亡率和再住院的复合结局的更高比值相关(HR:1.26;95%CI:1.02-1.56,p=0.03)。其他不良健康状况与全因死亡率和再住院的复合结局无显著相关性。

结论

在老年 AF 患者的多种不良健康状况中,多种合并症似乎是不良临床结局的重要决定因素。

临床试验注册

ChiCTR1800017204;注册日期:2018 年 7 月 18 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3e/11385685/0e58c957206e/CIA-19-1519-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3e/11385685/8b6869cb7387/CIA-19-1519-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3e/11385685/0e58c957206e/CIA-19-1519-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3e/11385685/8b6869cb7387/CIA-19-1519-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b3e/11385685/0e58c957206e/CIA-19-1519-g0002.jpg

相似文献

1
Impact of Adverse Health Conditions on Clinical Outcomes of Older People with Atrial Fibrillation: Insights from a Prospective Cohort Study.不良健康状况对老年心房颤动患者临床结局的影响:一项前瞻性队列研究的启示。
Clin Interv Aging. 2024 Sep 6;19:1519-1528. doi: 10.2147/CIA.S464044. eCollection 2024.
2
The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.移动医疗技术支持路径对合并多种疾病患者心房颤动相关不良事件的影响:mAFA-II 随机临床试验。
JAMA Netw Open. 2021 Dec 1;4(12):e2140071. doi: 10.1001/jamanetworkopen.2021.40071.
3
Implication of different frailty criteria in older people with atrial fibrillation: a prospective cohort study.不同衰弱标准对老年心房颤动患者的影响:一项前瞻性队列研究。
BMC Geriatr. 2023 Sep 27;23(1):604. doi: 10.1186/s12877-023-04330-1.
4
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation.心房颤动患者中与多种疾病、虚弱和营养不良相关的不良临床结局。
J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29.
5
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes.衰弱和心房颤动对老年急性冠状动脉综合征患者的影响。
Eur J Clin Invest. 2021 May;51(5):e13505. doi: 10.1111/eci.13505. Epub 2021 Feb 12.
6
Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index.使用 Charlson 合并症指数评估心房颤动的多种合并症及其对临床的影响。
Int J Cardiol. 2024 Mar 1;398:131605. doi: 10.1016/j.ijcard.2023.131605. Epub 2023 Nov 22.
7
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?多药治疗与心房颤动不良事件:主要病因还是多重合并症的反映?
Biomed Pharmacother. 2023 Feb;158:114064. doi: 10.1016/j.biopha.2022.114064. Epub 2022 Dec 7.
8
Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry.《房颤优化管理路径对伴有多种合并症和多种药物治疗的临床复杂中国房颤患者结局的影响:来自 ChiOTEAF 登记研究的报告》。
J Am Heart Assoc. 2022 Apr 5;11(7):e024319. doi: 10.1161/JAHA.121.024319. Epub 2022 Apr 4.
9
Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.75 岁及以上心房颤动患者共病与心血管终点事件及治疗效果的关系。
Am J Med. 2020 Oct;133(10):e554-e567. doi: 10.1016/j.amjmed.2020.03.038. Epub 2020 Apr 19.
10
Association between polypharmacy and 2-year outcomes among Chinese older inpatients: a multi-center cohort study.中文老年住院患者药物治疗方案种类与 2 年结局的相关性:一项多中心队列研究。
BMC Geriatr. 2024 Sep 9;24(1):748. doi: 10.1186/s12877-024-05340-3.

本文引用的文献

1
Burden of cardiometabolic disorders and lifetime risk of new-onset atrial fibrillation among men and women: the Rotterdam Study.心血管代谢疾病负担与新发心房颤动的终身风险:鹿特丹研究。
Eur J Prev Cardiol. 2024 Jul 23;31(9):1141-1149. doi: 10.1093/eurjpc/zwae045.
2
Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial.心房颤动患者的综合治疗 - ALL-IN 试验的预测异质治疗效果分析。
PLoS One. 2023 Oct 19;18(10):e0292586. doi: 10.1371/journal.pone.0292586. eCollection 2023.
3
Implication of different frailty criteria in older people with atrial fibrillation: a prospective cohort study.
不同衰弱标准对老年心房颤动患者的影响:一项前瞻性队列研究。
BMC Geriatr. 2023 Sep 27;23(1):604. doi: 10.1186/s12877-023-04330-1.
4
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry.欧洲心房颤动患者临床复杂性特征:一项来自欧洲观察性前瞻性心房颤动登记研究的报告。
Curr Probl Cardiol. 2023 Aug;48(8):101752. doi: 10.1016/j.cpcardiol.2023.101752. Epub 2023 Apr 20.
5
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry.房颤患者 ABC(房颤更好护理)路径的临床复杂性和影响:来自 ESC-EHRA EURObservational Research Programme in AF 一般长期注册研究的报告。
BMC Med. 2022 Sep 2;20(1):326. doi: 10.1186/s12916-022-02526-7.
6
The challenge of managing multimorbid atrial fibrillation: a pan-European European Heart Rhythm Association (EHRA) member survey of current management practices and clinical priorities.管理多重合并症心房颤动的挑战:一项泛欧欧洲心脏节律协会(EHRA)成员调查,涉及当前的管理实践和临床重点。
Europace. 2022 Dec 9;24(12):2004-2014. doi: 10.1093/europace/euac136.
7
Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.伴有高合并症负担的心房颤动患者的早期节律控制。
Circulation. 2022 Sep 13;146(11):836-847. doi: 10.1161/CIRCULATIONAHA.122.060274. Epub 2022 Aug 15.
8
Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals.心房颤动发病率的时间趋势和模式:一项基于340万个体的人群研究。
Lancet Reg Health Eur. 2022 Apr 25;17:100386. doi: 10.1016/j.lanepe.2022.100386. eCollection 2022 Jun.
9
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients.衰弱症在房颤患者中的患病率及其对结局的影响:一项纳入 118.7 万名患者的系统评价和荟萃分析。
Ageing Res Rev. 2022 Aug;79:101652. doi: 10.1016/j.arr.2022.101652. Epub 2022 May 31.
10
A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.一个在老年多病性心房颤动患者中实施综合护理的欧洲多国网络:AFFIRMO联盟。
Eur Heart J. 2022 Aug 14;43(31):2916-2918. doi: 10.1093/eurheartj/ehac265.